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A 29-residue synthetic peptide, LeuS3°-Leu-Tyr-Glu-Met-Leu-Ala-Gly-Gln-Ala-Pro-Phe-Glu-Gly-Glu-Asp-Glu-Asp - 
Glu-Leu-Phe-Gln-Ser-Ile-Met-Glu-His-Asn-Val-NH2 sss, corresponding topart of the catalytic domain of protein kinase 
C, is a potent activator of the enzyme, with a Ka of approx. 10/zM. Activation was 59+4% of that observed with 
phosphatidylserine, predominantly due to an increased Vm~, partially calcium-dependent, observed with all three isoen- 
zymes (~, p, ?), and resulted in autophosphorylation. It is proposed that the region between Gly s28 and Arg ss3 is part 
of the protein substrate binding region of protein kinase C and synthetic peptide analogs of this region activate the en- 
zyme by blocking the action of the enzyme's basic pseudosubstrate utoregulatory region. 
Protein kinase C; Enzyme activator; Peptide analog, synthetic; Substrate-binding region 
1. INTRODUCTION 
Protein kinase C (PK-C) is an important regu- 
latory enzyme involved in multiple cellular re- 
sponses [1]. The protein substrates phosphorylated 
by PK-C contain basic residues in proximity to the 
phosphorylated residue [2,3] that act as important 
specificity determinants. The enzyme's regulatory 
domain also contains a basic residue-rich region 
between residues 19 and 31, which is thought to act 
as a pseudosubstrate regulator binding to the active 
site [4]. However, it is not known where protein 
substrates or the pseudosubstrate bind to the 
catalytic domain. Comparisons between other pro- 
tein kinases [5] and nucleotide-binding proteins 
such as 3-phosphoglycerate kinase [6] provide a 
guide to the possible location of this protein 
substrate-binding re ion in PK-C. Taylor et al. [7] 
identified the ATP-binding motif in the cAMP- 
dependent protein kinase that consists of a glycine 
triad and a nearby lysine residue. PK-C contains an 
analogous motif beginning at Gly 349 and extending 
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to Lys 37t. The entire ATP-binding domain in the 
crystal structure of 3-phosphoglycerate kinase con- 
tains approx. 180 residues [6]. In the case of PK-C 
such a domain would extend from the glycine triad 
beginning at residue 349 to approximately Gly 528 
(180 residues). This region contains conserved 
acidic residues found in all members of the protein 
kinase family (fig. 1). Given the bilobal structure of 
some sugar kinases [6] it seems reasonable that 
components ofthe protein substrate-binding site of 
PK-C would be found at one or other ends of the 
ATP-binding domain. It seems reasonable that the 
protein binding site is located on the carboxyl- 
terminal end of the ATP-binding domain because 
the amino-terminus of the calmodulin-dependent 
protein kinase II is within 12 residues of the glycine 
triad [5]. The carboxyl-terminal boundary for the 
protein substrate-binding region is likely to be 
Arg 583 in PK-C because this is the most distal 
residue conserved in all protein kinases [5] and 
truncations near this residue in either the myosin 
light chain kinase [8] or pp60 src [9] retain their 
capacity to bind and phosphorylate substrates. 
Thus the ATP-binding and protein substrate- 
binding properties for all protein kinases would be 
expected in a 240 amino acid segment between the 
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glycine tr iad and  the distal conserved Arg.  Here,  
we show that a synthetic pept ide cor respond ing  to 
part  o f  the putat ive subst rate-b ind ing region is a 
potent  act ivator of  PK-C.  
2. MATERIALS  AND METHODS 
[7-32p]ATP was purchased from New England Nuclear and 
all other reagents and methods were as described [2]. The en- 
zyme was purified from rat brain and stored in buffer con- 
taining glycerol and Triton X-100 as described [2,10]. Phos- 
phorylation assays were performed in a volume of 40/A in 20 
mM Tris (pH 7.5), 12.5 mM MgC12, 0.5 mM EGTA, 0 or 0.75 
mM CaCl2, 300 /zM [A-nP]ATP (500 cpm/pmol), 50 /~M 
[Alag'l°LysUa~]GS (1-12) (synthetic peptide substrate from 
glycogen synthase [4]), 0.35/zg rat brain PK-C, plus activators 
as shown. PK-C isoenzymes were separated on hydroxyapatite 
[11]. Autophosphorylation was carried out for 5 min in a 
volume of 40/~1 containing 30 mM Tris (pH 7.4), 10 mM MgC12, 
1 mM EGTA, 200/zM ATP, 2/~g PK-C, and the activators Ca 
(calcium, 200/~M), PK-C [peptide PK-C (530-558) 250~M], PS 
(phosphatidylserine, 10/~g/ml) or PMA (1 #M). Reactions were 
terminated by addition of 2o70 SDS and the samples eparated on 
a 20 cm polyacrylamide (7.5°70) gel, dried and autoradio- 
graphed. 
3. RESULTS AND DISCUSSION 
The peptide, Leu53°-Leu-Tyr -Glu-Met-Leu - 
A la -G ly -G ln -A la -P ro -Phe-G lu -G ly -Asp-G lu -Asp-  
G lu  - Leu - Phe -G in  - Ser - l ie -Met  - G lu -  His -Asn-  Val - 
NH25~s, cor respond ing  to more  than  hal f  the se- 
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Fig. 1. Summary of the location of the catalytic and regulatory 
features of PK-C. The overall structure corresponds tothat pro- 
posed by Parker et al. [12]. The residues are numbered accor- 
ding to Knopf et al. [18]. The residues from the catalytic domain 
that share homology with all known serine, threonine and 
tyrosine protein kinases are shown in relation to the ATP-and 
protein substrate-binding re ions. 
quence between Gly 52s and  Arg 5s3 (fig. 1), was a po- 
tent  act ivator  o f  PK -C  (f ig.2A) with a Ka of  ap- 
prox.  10/~M and max imum act ivat ion of  59 + 4°7o 
(n = 12) compared  with phosphat idy lser ine.  
A l though phosphat idy lser ine-dependent  act ivat ion 
o f  the enzyme requires calc ium, act ivat ion by the 
acidic pept ide was only  part ia l ly  ca lc ium-depen-  
dent  [37 _+ 6°7o (n = 8)] (f ig.2A). The acidic pep- 
t ide pr imar i ly  increased the Vmax with modest  ef- 
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Fig.2. Activation of PK-C by the peptide PK-C(530-558). (A) 
Dose response for the peptide PK-C(530-558) in the absence 
(O) and presence (o) of calcium. (B) Dependence on ATP in the 
presence of 2.5/~g/ml phosphatidylserine (/x)or 50/LM peptide 
PK-C(530-558) (•) .  (C) Dependence onsubstrate kinetics in the 
presence of 2.5/zg/ml phosphatidylserine ( [] ) or 50/~M peptide 
PK-C(530-558) (.). 
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Table 1 
Comparison of activation of protein kinase C by synthetic 
peptides 
Sequence Concentration Activation 
(%) 
Phosphatidylserine 
PK-C(530-558) 
PK-C(530-549) 
PK-C(539-558) 
PK-C(539-549) 
Poly(Asp) (Mr 14000) 
(Asp)3o 
(Asp)21 
(Asph~ 
(Asp)lo 
Poly(GIu) (Mr 50000) 
10 #g/ml 
50 ,zM 
50 ,zM 
50 ,zM 
50 ,zM 
50 ,~M 
50 aM 
50 aM 
50 aM 
50 aM 
32.5 aM 
100 
47.5 
0.7 
0.6 
0.6 
20.6 
6.0 
14.7 
5.3 
0.9 
2.3 
Leu530 _ Leu- Tyr - Glu- Met - Leu - Ala - Gly - Gin - Ala 5s9 . Pro- Phe -
Glu-Gly-Glu-Asp-Glu-Asp-Glu549-Leu-Phe-Gln-Ser-Ile-Met - 
Glu-His-Asn-Val-NH2 ~Ss [polymers ofAsp are shown as (Asp)n 
where n is the length of the polymer] 
fects on the substrate Km for ATP (increasing from 
41 to 80 #M; fig.2B) and the peptide substrate Km 
(decreasing from 3.8 to 2.0#M; fig.2C). Activation 
by the peptide PK-C(530-558) was also observed 
with synthetic peptide substrates corresponding to
phosphorylation sites in the epidermal growth fac- 
tor receptor and ribosomal protein $6 [2] and to a 
lesser extent with histone. Since the peptide PK- 
C(530-558) did not increase the Km for peptide 
substrate or alter inhibition by the pseudosubstrate 
inhibitor PK-C(I 9-31) it is unlikely that the peptide 
activator PK-C(530-558) exerts its effects by 
binding to the peptide substrate. Furthermore, at 
saturating concentrations of phosphatidylserine 
there was no further increase in PK-C activity with 
the peptide activator PK-C(530-558). 
The structure-function requirements for activa- 
tion by the peptide PK-C(530-558) was investi- 
gated by preparing a series of shorter peptides 
(table 1); all three peptides were poor activators, in- 
dicating that the full length of the peptide was im- 
portant and that higher orders of structure may be 
important. Since the peptide PK-C(530-558) con- 
tains acidic residues the effect of polyaspartic and 
polyglutamic acid peptides were tested. Polyaspar- 
tic acid (Mr = 14000) was the most effective ac- 
tivator. In the range (Asp)lo to (Asp)3o there was an 
optimum at (Asp)21 (table 1). Since polyaspartic 
acid can partially mimic the peptide PK-C 
(530-558) it seems reasonable that activation 
depends on acidic amino acids but it is not yet clear 
as to which of the acidic residues present in the pep- 
tide PK-C(530-558) are required for activation. 
Rat brain is known to contain multiple PK-C 
isoenzymes [ 11 ] like other tissues [12,13]. The three 
major peaks of PK-C resolved by hydroxyapatite 
70000 
60000- 
50000- 
-¢  A 
~_ ~O000- 
E 
~' 30000- c 
~ 20000. 
13.. 
10000. 
i ! 
10 20 
/ 
/ 
/ 
/ /111 
- S - 
! i i i i i 
30 &0 50 60 70 80 
0 i 
90 100 
200 
100 
E 
c~ 
r~ 
Fraction Number 
Fig.3. Hydroxyapatite separation of PK-C isoenzymes. Results hown are for reactions with calcium (1::1); calcium, plus 5 #g/ml 
phosphatidylserine (m) and calcium, plus 50 #M peptide PK-C(530-558) (A). 
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chromatography [11], corresponding to the c~, 13 
and "r forms, were all activated by the peptide PK- 
C(530-558) (fig.3). 
The peptide PK-C(530-558) stimulated auto- 
phosphorylation f both PK-C forms (80-83 kDa) 
resolved on 7.5070 polyacrylamide gels (fig.4A). 
Autophosphorylation without calcium stimulated 
by the peptide PK-C(530-558) mimicked that by 
phorbol 1-myristate 2-acetate (PMA), although to 
a much lower extent (fig.4A). Autophosphory- 
lation in the presence of calcium plus peptide or 
calcium plus phosphatidylserine resulted in 
Fig.4. Autophosphorylation of PK-C. (A) Incubation i  the 
presence ofEGTA, Ca, or PS alone did not produce significant 
autophosphorylation. In the presence ofthe activators shown, 
an 80 kDa form of PK-C was always autophosphorylated. 
Higher molecular mass forms were also autophosphorylated 
with sizes ranging from 81 to 83 kDa depending on the activator. 
(B) Phosphopeptide mapping of the 80 kDa form with Staphy- 
lococcus aureus V8 protease [19] separated on a 15% poly- 
acrylamide gel. The autoradiograph of the phosphopeptide 
maps for PK-C(530-558) and PS/PK-C(530-558) is overexpos- 
ed 5-fold relative to the remaining phosphopeptide maps to 
facilitate comparison. Similar results were obtained in 4 
separate experiments on different PK-C preparations. 
phosphorylation of the 80 and 81 kDa forms 
(fig.4A) at the same sites (fig.4B). The peptide PK- 
C(530-558) therefore stimulates autophosphory- 
lation in the same way as the previously described 
activators with calcium modulating autophos- 
phorylation of one of the two sets of autophos- 
phorylation sites. 
Activation of PK-C by a fragment of its protein 
substrate-binding site is consistent with the 
pseudosubstrate regulatory model of this enzyme 
and may have important implications for other 
protein kinases. Inspection of the primary se- 
quences [5] of the cAMP-dependent protein 
kinase, casein kinase-II, myosin light chain kinase, 
and the pp60 s'c family of tyrosine protein kinases 
within the region corresponding to Gly 528 and 
Arg 583 in PK-C reveals potential substrate-binding 
regions containing acidic or basic residues com- 
plementary to their known protein substrate 
specificity requirements. The overall model of a 
protein kinase catalytic domain indicated here 
(fig. 1) is one of an ATP-binding core of approx. 
180 residues and a carboxyl-terminal 60-80-residue 
flap responsible for binding the protein substrate in 
appropriate apposition to the ATP. Previous af- 
finity labelling studies of the cAMP-dependent 
protein kinase with peptide substrate analogs 
[14,15] resulted in the labelling of residues within 
the ATP-binding region rather than the substrate- 
binding region identified here. However, this is 
readily explained, since the reactive groups were 
substituted in place of the serine phosphate accep- 
tor site of the peptide substrate, these would be ex- 
pected to face the ATP-binding region and there- 
fore label it. Location of the primary protein 
substrate-binding site between Gly 528 and Arg 583 
does not preclude contributions from residues on 
the ATP-binding region expected to be nearby in 
the three-dimensional structure. Indeed, the results 
of Levin et al. [16] with the cAMP-dependent 
protein kinase are an example of a point mutation 
in the ATP-binding domain modulating the in- 
teraction of the regulatory subunit, but not peptide 
substrates. The extent o which synthetic peptide 
analogs of the substrate-binding regions of other 
protein kinases can modulate their regulatory 
properties will depend on how well these peptides 
can mimic the structures present in the parent pro- 
teins in binding to pseudosubstrate s ructures. This 
may vary considerably just as synthetic peptides 
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corresponding to phosphorylat ion site sequences 
vary in their potency as substrates for particular 
protein kinases. The present results suggest hat it 
may be possible to manipulate genetically protein 
kinase specificities by exchanging substrate- 
b inding regions, analogous to the approaches 
taken to alter the hormone specificity of the 
tyrosine protein kinase receptor family [17]. 
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